Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.
about
Dapagliflozin for type 2 diabetes mellitusMice deficient in the insulin-regulated membrane aminopeptidase show substantial decreases in glucose transporter GLUT4 levels but maintain normal glucose homeostasisInsulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM).Effects of cellular ATP depletion on glucose transport and insulin signaling in 3T3-L1 adipocytes.Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.Astragalus polysaccharides attenuates TNF-α-induced insulin resistance via suppression of miR-721 and activation of PPAR-γ and PI3K/AKT in 3T3-L1 adipocytesRapid upregulation of sodium-glucose transporter SGLT1 in response to intestinal sweet taste stimulation.Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors.Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia.Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats.In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.Reduction in reactive oxygen species production by mitochondria from elderly subjects with normal and impaired glucose toleranceFacilitative glucose transporters: regulatory mechanisms and dysregulation in diabetesIn vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicityRenal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitusTargeting glycogen synthase kinase-3 in insulin signalling.Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic controlSodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes.Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport.A new approach to glucose control in type 2 diabetes: the role of kidney sodium-glucose co-transporter 2 inhibition.Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with type 2 diabetes mellitus.SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus.SGLT2 inhibition: a novel prospective strategy in treatment of diabetes mellitus.Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus.Protein O-GlcNAcylation in diabetes and diabetic complications.Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport.Hypothalamic neurones governing glucose homeostasis.Clinical Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor.The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -/- mice fed a western diet.Effect of streptozotocin-induced diabetes on GLUT-4 phosphorylation in rat adipocytes.Glucosamine-induced insulin resistance in 3T3-L1 adipocytes.In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution.Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress.Impaired glucose transport in skeletal muscle but normal GLUT-4 tissue distribution in glucose-infused rats.Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes.
P2860
Q24234557-3CEB518B-792F-45AD-A2EB-EDB094F1E889Q28589946-04B66292-998A-4214-BA09-3A8C3A606B74Q30434577-B953E481-F312-41A2-8CF5-046D31E08350Q31919627-1C0413EE-A8A6-4A9A-857C-7681A3E255FFQ33451134-3F21253D-A68F-49A8-8513-923F0C501F7BQ33733133-F05AE2AB-DFC7-46B5-9867-71CE812AE130Q34010026-18FF2C91-AA57-49F9-9FDD-B76571EC7024Q34219847-9FF84DF4-D4BE-4234-9FE5-6542708C9F30Q34224574-4299C315-C5B3-47BF-9657-601C7DA753C4Q34265419-09091DD7-2425-4025-A020-1D9B6516F7ACQ34718208-FCC1238A-F99E-4D98-A7DC-82854323CFC9Q35123509-CCD8079F-4A8F-458D-85C5-62E4E4138B14Q35601498-6F5A77DA-E5FE-4C2C-9535-8E1C5418FCC5Q35750029-BDDC3DF0-AEA2-4931-94A9-736FE47E4B66Q35768419-6516D83B-DE20-4F4F-BB9D-BB1AC42DCBA8Q36345951-6311D548-E321-45C8-B6AD-135523CA4DBDQ36481069-86870CB2-CD73-49D3-BAAE-6A4CBF9C13EDQ36702223-2DFF6582-67F6-4FC8-B4DF-418E4D2DF996Q37139427-CFF3DFB9-9BEA-4C84-AD20-10810580E6DFQ37372990-E5A5AEBD-939A-47BC-AECE-558503D114AFQ37421154-F935CC4F-C1B9-4894-9D11-FF084577AC41Q37890777-FD39F624-B4B3-46AA-A037-2F53239B2461Q37960123-A91326A9-B158-48F2-B0FD-EA31010CB22DQ38077305-5E6B56C3-7644-4737-A865-BFE4DAC26B08Q38084363-C5078904-BD94-48FA-9B53-AF250C09C49DQ38086816-3E56A317-A640-44CD-ACCC-8185396D1F32Q38132916-7CF425CB-E18B-430F-B161-89A30F681D85Q38201162-F052F689-B1EF-46AE-BECA-B2D7242B121FQ38380733-47B025C3-88FB-4057-8271-F08124F60B3FQ38515085-1865F27B-034F-4F7B-89F9-B260539596DBQ38730067-97B188BB-A47F-4943-92F7-477C7FCEED09Q41020712-E21E539E-E434-45F6-9417-2D6952E1F06DQ41715673-2BC9CF1C-682D-4212-AECE-55860E923442Q42526429-7B6BAA87-E413-4D3C-AB01-9EC01622B664Q43565222-D11AC67D-3BDD-4D88-A6E2-B7601222A2FDQ44473636-C7A21C15-DD86-4E72-8645-AF22347E38F7Q46042931-B4C70E04-7F4C-46BB-8AED-77601C36C7EBQ54248306-DE0A6313-6DA6-4B39-909C-002F859CA322
P2860
Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.
description
1991 nî lūn-bûn
@nan
1991 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Normalization of blood glucose ...... e transporter gene expression.
@ast
Normalization of blood glucose ...... e transporter gene expression.
@en
Normalization of blood glucose ...... e transporter gene expression.
@nl
type
label
Normalization of blood glucose ...... e transporter gene expression.
@ast
Normalization of blood glucose ...... e transporter gene expression.
@en
Normalization of blood glucose ...... e transporter gene expression.
@nl
prefLabel
Normalization of blood glucose ...... e transporter gene expression.
@ast
Normalization of blood glucose ...... e transporter gene expression.
@en
Normalization of blood glucose ...... e transporter gene expression.
@nl
P2093
P2860
P356
P1476
Normalization of blood glucose ...... se transporter gene expression
@en
P2093
L Rossetti
R A DeFronzo
S W Cushman
P2860
P304
P356
10.1172/JCI115031
P407
P577
1991-02-01T00:00:00Z